Across the tech industry, many of AI's own leaders are calling for oversight — self-imposed or from government. That debate is on, but where it will land is anyone's guess. Joe Grogan takes a different tack: the biggest threat in health care AI may not be too little regulation, but the wrong kind. And he has seen regulation from the seats where it gets made: the White House Domestic Policy Council, the federal health care budget at OMB, and before Washington, the industry side of bringing a cure for Hepatitis C to patients. Chip and Grogan discuss the federal government's proper role in regulating generative AI, the growing patchwork of state AI laws, why CMS reimbursement structures need to change, and how Europe's cautious approach is impeding the technology's growth. Grogan closes with his two biggest worries: fear-driven policy that bans innovation outright, and the risk to patients' most sensitive data as AI's appetite for it grows.
","author_name":"KFF"}